Scientists designed and tested fluorescent molecules called “FibrilPaint” that bind exclusively to the long, thread-like ...
Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
La maladie d’Alzheimer se manifeste généralement de façon discrète. D’où l’importance de repérer les symptômes précurseurs, ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...
Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback